{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:47:28Z","timestamp":1782211648905,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02343-4","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:15:10Z","timestamp":1773886510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The genetic landscape of breast cancer in young women from Morocco: implications for diagnosis and treatment"],"prefix":"10.1186","volume":"19","author":[{"given":"Brahim","family":"El Hejjioui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhamid","family":"Bouramtane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Bouguenouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreddine","family":"Elmakhzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ahakoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moulay Abdelilah","family":"Melhouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Ouldim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","unstructured":"Silva JDDE et al. Mortality of Young Women due to Breast Cancer in Low, Middle and High-Income Countries: Systematic Literature Review and Meta-Analysis. Asian Pac J Cancer Prev. 2024;25(7):2219\u20132227. https:\/\/doi.org\/10.31557\/APJCP.2024.25.7.2219.","DOI":"10.31557\/APJCP.2024.25.7.2219"},{"key":"2343_CR2","doi-asserted-by":"publisher","unstructured":"Zhu JW, Charkhchi P, Adekunte S, Akbari etMR. What Is Known about Breast Cancer in Young Women? Cancers. 2023;15(6). https:\/\/doi.org\/10.3390\/cancers15061917.","DOI":"10.3390\/cancers15061917"},{"key":"2343_CR3","doi-asserted-by":"publisher","unstructured":"Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, et, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69(3):313\u20137. https:\/\/doi.org\/10.1007\/s13304-017-0424-1.\u00a0","DOI":"10.1007\/s13304-017-0424-1"},{"key":"2343_CR4","doi-asserted-by":"publisher","unstructured":"Kataoka A, et al. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry. Breast Cancer Res Treat. 2016;160(1):163\u201372. https:\/\/doi.org\/10.1007\/s10549-016-3984-8.\u00a0","DOI":"10.1007\/s10549-016-3984-8"},{"key":"2343_CR5","doi-asserted-by":"publisher","unstructured":"Paluch-Shimon S et al. oct., ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). The Breast. 2017;35:203\u2013217. https:\/\/doi.org\/10.1016\/j.breast.2017.07.017.","DOI":"10.1016\/j.breast.2017.07.017"},{"key":"2343_CR6","doi-asserted-by":"publisher","unstructured":"Tesch ME et, Partridge AH. Treatment of Breast Cancer in Young Adults. Am Soc Clin Oncol Educ Book. 2022;(42):795\u2013806. https:\/\/doi.org\/10.1200\/EDBK_360970.","DOI":"10.1200\/EDBK_360970"},{"key":"2343_CR7","doi-asserted-by":"publisher","unstructured":"Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28(6):1167\u20131180. https:\/\/doi.org\/10.1007\/s12282-020-01148-2.","DOI":"10.1007\/s12282-020-01148-2"},{"key":"2343_CR8","doi-asserted-by":"publisher","unstructured":"Lee A, Moon B-I, et, Kim TH. BRCA1\/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies. Annals of Laboratory Medicine. 2020;40(2):114\u2013121. https:\/\/doi.org\/10.3343\/alm.2020.40.2.114.","DOI":"10.3343\/alm.2020.40.2.114"},{"key":"2343_CR9","doi-asserted-by":"publisher","unstructured":"Ponti G et al. Hereditary breast and ovarian cancer: from genes to molecular targeted therapies. Crit Rev Clin Lab Sci. 2023;60(8):640\u2013650. https:\/\/doi.org\/10.1080\/10408363.2023.2234488.","DOI":"10.1080\/10408363.2023.2234488"},{"key":"2343_CR10","doi-asserted-by":"publisher","unstructured":"Hani ME, Jdioui W, Zerkaoui M, Cherrah Y, Izgua AT, et, Serragui S. EE570 Estimation of Direct Medical Costs Associated With Genetic Consultations Among Moroccan Children With Rare Diseases: A Single-Center Retrospective Cost Analysis. Value in Health. 2022;25(12):S167\u2013S168. https:\/\/doi.org\/10.1016\/j.jval.2022.09.810.","DOI":"10.1016\/j.jval.2022.09.810"},{"key":"2343_CR11","doi-asserted-by":"publisher","unstructured":"Khyatti M, et al. Precision medicine in Morocco: State of art and challenges for implementation. J Cancer Policy. 2025;45:100598. https:\/\/doi.org\/10.1016\/j.jcpo.2025.100598.","DOI":"10.1016\/j.jcpo.2025.100598"},{"key":"2343_CR12","doi-asserted-by":"publisher","unstructured":"Elalaoui SC et al. Mutational spectrum of BRCA1\/2 genes in Moroccan patients with hereditary breast and\/or ovarian cancer, and review of BRCA mutations in the MENA region. Breast Cancer Res Treat. 2022;194(1):187\u2013198. https:\/\/doi.org\/10.1007\/s10549-022-06622-3.","DOI":"10.1007\/s10549-022-06622-3"},{"key":"2343_CR13","doi-asserted-by":"publisher","unstructured":"Melki R, Melloul M, Aissaoui S, Harroudi TEL, et, Boukhatem N. Increased prevalence of the founder BRCA1 c.5309G\u2009>\u2009T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling. BMC Cancer. 2023;23(1):339. https:\/\/doi.org\/10.1186\/s12885-023-10822-5.","DOI":"10.1186\/s12885-023-10822-5"},{"key":"2343_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7150\/jgen.61713","volume":"9","author":"A Laraqui","year":"2021","unstructured":"Laraqui A, et al. \u00ab Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in Morocco \u00bb. J Genomics. 2021;9:43\u201354. https:\/\/doi.org\/10.7150\/jgen.61713.","journal-title":"J Genomics"},{"key":"2343_CR15","doi-asserted-by":"publisher","unstructured":"El Ansari FZ et al. Screening of BRCA1\/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC). BMC Cancer. 2020;20(1):747. https:\/\/doi.org\/10.1186\/s12885-020-07250-0.","DOI":"10.1186\/s12885-020-07250-0"},{"key":"2343_CR16","unstructured":"\u00ab Detection of germline variants in Brazilian breast cancer patients using multigene panel testing | Scientific Reports \u00bb. Accessed on: March 11, 2025. Available at: https:\/\/www.nature.com\/articles\/s41598-022-07383-1."},{"key":"2343_CR17","doi-asserted-by":"publisher","unstructured":"Chan GHJ et al. Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers. Oncotarget. 2018;9(55):30649\u201330660. https:\/\/doi.org\/10.18632\/oncotarget.25769.","DOI":"10.18632\/oncotarget.25769"},{"key":"2343_CR18","doi-asserted-by":"publisher","unstructured":"Bethea TN et al. Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women. Cancer Epidemiol Biomarkers Prev. 2016;25(2):366\u2013373. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-1068.","DOI":"10.1158\/1055-9965.EPI-15-1068"},{"key":"2343_CR19","doi-asserted-by":"publisher","unstructured":"Geyer CE et al. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer. Ann Oncol. 2022;33(12,):1250\u20131268. https:\/\/doi.org\/10.1016\/j.annonc.2022.09.159.","DOI":"10.1016\/j.annonc.2022.09.159"},{"key":"2343_CR20","doi-asserted-by":"publisher","unstructured":"Robson M et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N Engl J Med. 2017;377(6):523\u2013533. https:\/\/doi.org\/10.1056\/NEJMoa1706450.","DOI":"10.1056\/NEJMoa1706450"},{"key":"2343_CR21","doi-asserted-by":"publisher","unstructured":"Litton JK et al. Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. New England Journal of Medicine. 2018;379(8):753\u2013763. https:\/\/doi.org\/10.1056\/NEJMoa1802905.","DOI":"10.1056\/NEJMoa1802905"},{"key":"2343_CR22","doi-asserted-by":"publisher","unstructured":"Keske A et al. Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers. Breast Cancer Res Treat. 2024;204(1):151\u2013158. https:\/\/doi.org\/10.1007\/s10549-023-07173-x.","DOI":"10.1007\/s10549-023-07173-x"},{"key":"2343_CR23","doi-asserted-by":"publisher","unstructured":"Vietri MT et al. Expanding the Genomic Landscape of HBOC and Cancer Risk Among Mutation Carriers. International Journal of Molecular Sciences. 2025;26(13):5928. https:\/\/doi.org\/10.3390\/ijms26135928.","DOI":"10.3390\/ijms26135928"},{"key":"2343_CR24","doi-asserted-by":"publisher","unstructured":"Anaclerio F, et al. Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis. Front Genet. 2023;14. https:\/\/doi.org\/10.3389\/fgene.2023.1060504.","DOI":"10.3389\/fgene.2023.1060504"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02343-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:00:13Z","timestamp":1782208813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02343-4","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: Acknowledgement section has been updated to include: The authors would like to acknowledge the financial support provided by Institut de Recherche sur le Cancer (IRC) (www.irc.ma) under the Scientific Publication Grant Program (Ref: 1829\/2026) for the publication of this article.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee for Biomedical Research of Mohammed V University, Rabat Faculty of Medicine and Pharmacy and Rabat Faculty of Dentistry (reference number: CERB 08\u201324). All procedures involving human participants were conducted in accordance with the ethical standards of the institutional research committee and in compliance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}